Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
79 hedge funds and large institutions have $41.1M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 21 reducing their positions, and 18 closing their positions.
5% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 21
5% less funds holding
Funds holding: 83 → 79 (-4)
5% less capital invested
Capital invested by funds: $43.4M → $41.1M (-$2.26M)
17% less call options, than puts
Call options by funds: $96K | Put options by funds: $116K
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$2.4M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.59M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.04M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$856K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$689K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.61M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.25M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$727K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$686K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$686K |
FRTX Hedge Fund Activity: Q4 2013 in Review
79 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q4 2013, worth a combined $41.1M — down 5.2% from $43.4M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of FRTX and 14 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 20 added.
The largest buyer was Ariel Investments, adding an estimated $2.4M. The largest seller was Federated Hermes, exiting entirely with an estimated $3.61M sold.
- 79 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q4 2013, down from 83 in Q3 2013.
- Funds reported $41.1M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q4 2013, down 5.2% quarter-over-quarter.
- 14 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q4 2013 and 18 closed out, a net change of -4 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q4 2013 was Ariel Investments, an estimated $2.4M added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q4 2013 was Federated Hermes, an estimated $3.61M sold.
Based on aggregated 13F filings for Q4 2013.